Search clinical trials for: Citalopram MI

Total 871 results

Sheba Medical Center
H. Lundbeck A/S

Unknown

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Depressive Syndrome

Israel
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
Tri-Service General Hospital

Completed

Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems

Anxiety Disorders | Sleep Apnea

Taiwan
Kunming Medical University
Chinese Academy of Sciences

Completed

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

Depression | Depression Secondary to Other Disease

China
VA Nebraska Western Iowa Health Care System
Forest Laboratories

Completed

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

PTSD

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Treatment Response of Geriatric Depression (ERP)

Depression

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

fMRI Studies of Emotional Brain Circuitry in People With Major Depression

Depression
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms (Lexapro)

Depressive Disorder, Major

China
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Aging Brain Changes, Executive Dysfunction and Depression (FA)

Depression
Weill Medical College of Cornell University

Completed

Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression

Depression

United States
Massachusetts General Hospital
Forest Laboratories

Completed

Influence of Escitalopram on Fear Conditioning

Fear Conditioning
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Biomarkers for Outcomes In Late-life Depression (BOLD) (BOLD)

Major Depressive Disorder

United States
Seoul National University Hospital

Unknown

Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

Korea, Republic of
Beitou Armed Forces Hospital, Taipei, Taiwan

Unknown

The Effects of Escitalopram on Cytokines (BAFH)

Depression

Taiwan
Pharmacology Research Institute

Unknown

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Charite University, Berlin, Germany
H. Lundbeck A/S

Completed

Investigation of a Combination Treatment of Escitalopram and rTMS

Major Depressive Disorder

Germany
Community Pharmacology Services Ltd

Completed

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Major Depressive Disorder

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)

Depression | Anxiety | In Vitro Fertilization

Israel
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Carcinomas

France
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram for the Treatment of Self-Injurious Skin Picking

Impulse Control Disorders

United States
Forest Laboratories

Completed

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Major Depressive Disorder

United States
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

United States
Psychiatric Hospital, Hillerod
Amager Hospital; Psychiatric Center Ballerup; Psychogeriatric Unit, CU Hospital... and other collaborators

Terminated

Treatment of Depression in the Elderly

Depression

Denmark
Indiana University
Patient-Centered Outcomes Research Institute; Four County Counseling Center; Places...

Completed

The Impact of Burnout on Patient-Centered Care: A Comparative Effectiveness Trial in Mental Health

Burnout | Quality of Care

United States
Florida State University

Completed

KNA Proof-of-Concept

Adherence, Treatment | Retention | Cognitive Impairment, Mild

United States
Qazvin University Of Medical Sciences

Completed

Improving Adherence to Medication After Coronary Artery Bypass Surgery (CABG) in Older Adults

Coronary Artery Bypass Grafting (CABG) Surgery

Iran, Islamic Republic of
Air Liquide Healthcare Spain
Hospital Pedro Hispano; Hospital Sao Joao

Unknown

PIMA - Individualized Adherence Improvement Plan (PIMAGASOXMED)

Sleep Apnea, Obstructive

Portugal
University of Michigan Rogel Cancer Center
Unity Health Toronto

Completed

Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy

Stomach Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Gastrointestinal Cancer

United States
The University of Hong Kong-Shenzhen Hospital

Completed

Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China

Diabete Type 2
Bristol-Myers Squibb

Completed

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) (BENEFIT)

Kidney Transplantation | Chronic Kidney Failure

United States, Argentina, Australia, Germany, Italy, South Africa, Spain, Brazil, Mexico, Belgium, France, Hungary, Switzerland, India, Canada, Austria, Czech Republic, Poland, Israel, Sweden, Turkey
Anne Birgitte Raben
University of Nottingham; University of Helsinki; Wageningen University; University... and other collaborators

Completed

Effect of Diet and Physical Activity on Incidence of Type 2 Diabetes (PREVIEW)

Obesity | Pre-diabetes

Spain, Denmark, Australia, Bulgaria, Finland, Netherlands, New Zealand, United Kingdom
NYU Langone Health
National Institute on Aging (NIA)

Recruiting

Aβ Dynamics in LLMD

Alzheimer Disease | Major Depressive Disorder

United States
KRL Hospital, Islamabad
Dow University of Health Sciences; Khyber Medical College, Peshawar; Quaid-e-Azam...

Completed

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Major Depressive Disorder

Pakistan
Laureate Institute for Brain Research, Inc.

Terminated

Adherence to Antidepressant Treatment in Subjects With Depression

Depression

United States
University of Texas Southwestern Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (TAKEDA)

Insomnia | Major Depressive Disorder

United States
University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
University of Washington
National Institutes of Health (NIH); Forest Laboratories

Terminated

Sinusitis and Facial Pain Disorders Anti-Depression Trial (SFPAT)

Depression | Chronic Sinusitis | Facial Pain Disorder

United States
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Treatment of Depression in Adults

Depression

United States, Italy
University of Virginia
National Cancer Institute (NCI); University of Tennessee

Completed

Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit (PACE)

Smoking Cessation

United States
Center for Vision Development, New Market, Maryland

Unknown

How Well do Patients With Traumatic Brain Injury Learn New Material Using Learning Styles in Online Science Classrooms? (CVD)

Brain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Brain Injury, Chronic | Injury, Brain, Traumatic

United States
University of Missouri, Kansas City
National Cancer Institute (NCI)

Completed

Testing Counseling Styles to Motivate Smokers to Quit

Smoking | Tobacco Use | Nicotine Dependence

United States
Markus KOSEL
University Hospital, Geneva; H. Lundbeck A/S; University Hospital, Basel, Switzerland and other collaborators

Terminated

EScitalopram PIndolol ONset of Action (ESPION)

Unipolar Depression

Switzerland
Stanford University
National Institute of Mental Health (NIMH)

Completed

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

Insomnia | Major Depressive Disorder

United States
New York State Psychiatric Institute

Completed

Developing New Clinical Management Strategies

Major Depressive Disorder

United States
Chinese University of Hong Kong

Completed

SSRI Study for Functional Dyspepsia (SS)

Depression | Dyspepsia | Anxiety

Hong Kong
Weill Medical College of Cornell University
Forest Laboratories

Terminated

Lexapro for Major Depression in Patients With Epilepsy

Epilepsy | Major Depression

United States
Duke University
St. Louis University

Completed

Escitalopram Treatment of Night Eating Syndrome

Night Eating Syndrome

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients (Cipralex&GBM)

Depression | GBM

Israel

Search clinical trials for: Citalopram MI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations